See also this year's filing and all EDGAR filings for this company.
PDF Report 0001677077_2022_Alzamend_Neuro_Inc.pdf
Logs
warning | Missing logo | subcommand.report | {} |
info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001677077')"} |
Graph
Absolute values for 0001677077, Alzamend Neuro Inc.
xvar | xval | |
---|---|---|
0 | AssetsCurrent | 2,912,590 |
1 | IntangibleAssetsNetIncludingGoodwill | 0 |
2 | PropertyPlantAndEquipmentNet | 0 |
3 | remainder_Assets | 0 |
4 | LiabilitiesCurrent | 899,643 |
5 | LiabilitiesNoncurrent | 0 |
6 | remainder_Liabilities | 0 |
7 | CostOfGoodsAndServicesSold | 0 |
8 | SellingGeneralAndAdministrativeExpense | 3,641,172 |
9 | ResearchAndDevelopmentExpense | 1,310,716 |
10 | remainder_Expenses | 0 |
11 | remainder_Revenues | 0 |
12 | remainder_NetIncome | -94,679 |
13 | remainder_ComprehensiveNetIncome | 0 |
yvar | yval | |
---|---|---|
0 | Assets | 2,912,590 |
1 | Liabilities | 899,643 |
2 | Expenses | 4,951,888 |
3 | Revenues | 0 |
4 | StockholdersEquity | 2,012,947 |
5 | NetIncome | -5,046,567 |
6 | ComprehensiveNetIncome | -5,046,567 |
7 | BaseVar | 4,429,400 |
8 | EconomicCapitalRatio | -0.831 |